We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
GMED

Price
72.59
Stock movement up
+1.61 (2.27%)
Company name
Globus Medical
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
8.26B
Ent value
8.65B
Price/Sales
3.33
Price/Book
2.03
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
90.22
Forward P/E
21.26
PEG
-
EPS growth
-7.04%
1 year return
36.68%
3 year return
-1.21%
5 year return
11.24%
10 year return
11.18%
Last updated: 2025-04-11

iO Charts is a Seeking Alpha partner

DIVIDENDS

GMED does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E90.22
Price to OCF19.90
Price to FCF28.10
Price to EBITDA19.66
EV to EBITDA20.60

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales3.33
Price to Book2.03
EV to Sales3.49

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count113.74M
EPS (TTM)0.66
FCF per share (TTM)2.13

Income statement

Loading...
Income statement data
Revenue (TTM)2.48B
Gross profit (TTM)1.35B
Operating income (TTM)164.47M
Net income (TTM)91.51M
EPS (TTM)0.66
EPS (1y forward)3.41

Margins

Loading...
Margins data
Gross margin (TTM)54.53%
Operating margin (TTM)6.64%
Profit margin (TTM)3.69%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash622.77M
Net receivables588.05M
Total current assets2.06B
Goodwill1.43B
Intangible assets842.78M
Property, plant and equipment1.13B
Total assets5.09B
Accounts payable57.54M
Short/Current long term debt534.56M
Total current liabilities818.07M
Total liabilities1.02B
Shareholder's equity4.07B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)414.97M
Capital expenditures (TTM)121.20M
Free cash flow (TTM)293.77M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity2.25%
Return on Assets1.80%
Return on Invested Capital2.03%
Cash Return on Invested Capital6.50%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open70.78
Daily high72.83
Daily low69.65
Daily Volume1.16M
All-time high93.32
1y analyst estimate92.69
Beta1.17
EPS (TTM)0.66
Dividend per share-
Ex-div date-
Next earnings date5 May 2025

Downside potential

Loading...
Downside potential data
GMEDS&P500
Current price drop from All-time high-22.21%-12.89%
Highest price drop-47.91%-56.47%
Date of highest drop13 Nov 20239 Mar 2009
Avg drop from high-14.77%-11.07%
Avg time to new high20 days12 days
Max time to new high807 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
GMED (Globus Medical) company logo
Marketcap
8.26B
Marketcap category
Mid-cap
Description
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Employees
5000
Investor relations
-
SEC filings
CEO
David M. Demski
Country
USA
City
Audubon
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...